Sionna Therapeutics, Inc. (SION) › Cash & EquivalentsSionna Therapeutics, Inc. (SION) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $37.79M2025: $58.45M$58.45M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$58.45M+54.7%2024$37.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share